Welcome to our dedicated page for SCOTTS MIRACLE-GRO CO SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SCOTTS MIRACLE-GRO CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SCOTTS MIRACLE-GRO CO's regulatory disclosures and financial reporting.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Kingdon Mark D reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) director Mark D. Kingdon reported an award of 118 Dividend Equivalent Rights on September 4, 2026. These rights accrue on DSU or RSU grants and become exercisable proportionately with those underlying units. Each right is the economic equivalent of one common share, bringing his direct holdings to 791 rights.
SCOTTS MIRACLE-GRO CO (SMG) director Adam Hanft reported an acquisition of derivative-based compensation on September 4, 2026. He received a grant of 118 Dividend Equivalent Rights, each economically equivalent to one common share and tied to existing DSU or RSU grants, bringing his directly held Dividend Equivalent Rights to 791 in total.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC. Miaritis Nick reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO (SMG) reported that EVP & Chief Brand Officer Nick Miaritis received a grant of 72 Dividend Equivalent Rights on September 4, 2026. These rights, each economically equivalent to one common share, accrued on existing DSU or RSU grants, bringing his directly held dividend equivalent rights to 340.
Scotts Miracle-Gro Co (SMG) reported that its EVP, CFO & CAO, Mark J. Scheiwer, acquired equity-linked awards. On September 4, 2026 he received 15.571 phantom stock units tied to common shares and 47 dividend equivalent rights, and held 1,436.158 phantom units and 500 dividend equivalent rights afterward. Phantom stock is payable in cash after employment termination, and each phantom unit or dividend equivalent right is economically equivalent to one common share. He also reported 2.808 additional common shares on August 31, 2026, for total direct holdings of 15,389.415 common shares plus 493.482 shares held indirectly through a 401(k) plan.
SCOTTS MIRACLE-GRO CO (SMG) executive Christopher Hagedorn, EVP & Chief Strategy Officer, reported an “other” acquisition transaction of 4.063 common shares on August 31, 2026, at a reported price of $53.41 per share. Following this small adjustment, his directly held position is 57,555.9284 common shares.
SCOTTS MIRACLE-GRO CO (SMG) director Brian E. Sandoval reported an acquisition of 179 Dividend Equivalent Rights on September 4, 2026. These rights accrued on existing DSU or RSU grants and are each economically equivalent to one common share of SMG. Following this award, he holds 1,143 Dividend Equivalent Rights directly. No Rule 10b5-1 trading plan is reported in connection with this transaction.
SCOTTS MIRACLE-GRO CO (SMG) reports a leadership change in its executive team. On August 29, 2026, the company and Christopher J. Hagedorn agreed that he will depart his role as Executive Vice President & Chief Strategy Officer, effective September 30, 2026.
The report is filed under the category covering departures of certain officers and related arrangements, and does not provide additional details on succession, compensation changes, or reasons for the departure.
SCOTTS MIRACLE-GRO CO (symbol: SMG) is the issuer of record for a Form 4 filing submitted to the SEC.
SCOTTS MIRACLE-GRO CO (SMG) has amended its Master Receivables Purchase Agreement with JPMorgan Chase Bank, N.A. to extend the receivables financing program. The Purchase Termination Date was moved from September 1, 2026 to August 31, 2027, maintaining the existing structure.
Under this receivables facility, the Sellers may sell, and JPMorgan may purchase on an uncommitted, weekly basis, up to $750 million of eligible customer accounts receivable generated from sales to five specified customers. The Scotts Company LLC, as Servicer, continues to service the sold receivables for a 20 basis point servicer fee. The facility remains non-recourse to the Sellers and the Company other than defined Recourse Obligations, which are supported by $75 million of standby letters of credit issued under the Company’s senior secured revolving facility. The Company continues to expect to use proceeds from receivables sales for general corporate purposes.
Scotts Miracle-Gro Co director Mark D. Kingdon reported a sale of 831 Common Shares on 2026-08-10 in a non-derivative transaction. The shares were sold at a price of $61.645 per share, leaving him with 10,827 Common Shares held by direct ownership.